Pharmaceuticals

Biguanides Market Anticipated to Reach $5.97 Billion by 2030

March 18, 2026April 6, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Will Be The Estimated Market Valuation Of The Biguanides Market By The End Of 2030?

The biguanides market has experienced consistent expansion in recent years. It is projected to grow from $5.11 billion in 2025 to $5.28 billion in 2026, at a compound annual growth rate (CAGR) of 3.4%. The historical increase can be attributed to various factors, including the rising prevalence of type 2 diabetes, greater awareness of metabolic disorders, an increase in the availability of generic biguanides, the adoption of oral antidiabetic medications, and progress in liver-targeted therapies.

The biguanides market size is projected to experience steady growth over the next few years. It is anticipated to expand to $5.97 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 3.1%. The expansion foreseen in the forecast period is primarily driven by factors such as the increasing demand for personalized medicine, the broader implementation of telemedicine for diabetes care, a rising incidence of PCOS, the continued development of combination therapies, and government initiatives that promote chronic disease management. Significant trends during this period are expected to include personalized diabetes management solutions, the evolution of combination therapies, broadened indications extending beyond type 2 diabetes, the adoption of home healthcare and remote patient monitoring, and the availability of cost-effective generic biguanides.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=15735&type=smp

Which Market Drivers Are Supporting The Expansion Of The Biguanides Market?

The increasing incidence of diabetes is anticipated to fuel the expansion of the biguanides market in the future. Diabetes, a persistent metabolic condition, is characterized by elevated blood glucose levels resulting from inadequate insulin generation or dysfunctional insulin activity. The growing occurrence of diabetes stems from shifts in lifestyle, an aging global population, and enhanced diagnostic understanding. The biguanides market aids in managing diabetes by boosting insulin sensitivity, decreasing glucose production in the liver, and contributing to reduced blood sugar levels for those with type 2 diabetes. As an illustration, data from March 2024, released by the Office for Health Improvement & Disparities (OHID), a government body in the UK, indicated that between March 2022 and March 2023, there was a 22% increase in the proportion of individuals with type 1 diabetes undergoing all eight prescribed care processes. For type 2 diabetes, this percentage rose by 21%. Furthermore, the segment achieving target HbA1c levels reached 37.9%, marking an unprecedented high. Consequently, the expanding prevalence of diabetes is serving as a catalyst for the biguanides market’s growth.

Which Segment Classifications Shape The Biguanides Market?

The biguanides market covered in this report is segmented –

1) By Type: Metformin, Phenformin, Other Types

2) By Dosage Form: Tablets, Oral Solutions

3) By Formulation: Immediate Release, Extended Release

4) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

Subsegments:

1) By Metformin: Immediate-Release Metformin, Extended-Release Metformin

2) By Phenformin: Phenformin Hydrochloride

3) By Other Types: Buformin, Metformin Combinations

How Are Trends Impacting The Biguanides Market?

Companies operating in the biguanide market are concentrating on developing advanced solutions, such as extended-release biguanide formulations, to enhance patient compliance, improve glycemic control, and reduce gastrointestinal side effects. These extended-release biguanide formulations are medications designed to release their active component gradually over time, which helps in maintaining stable blood concentrations, improving tolerability, and supporting better long-term adherence for individuals managing diabetes. For example, in August 2023, Dr. Reddy’s Laboratories, an India-based biotechnology company, introduced saxagliptin and metformin hydrochloride extended-release tablets. This product is a USFDA-approved generic version of KOMBIGLYZE XR, combining saxagliptin, a DPP-4 inhibitor, with metformin, a biguanide, thereby offering adults with type 2 diabetes mellitus an effective once-daily treatment choice. This option assists in achieving improved glycemic control when used with diet and exercise, while also enhancing adherence due to its extended-release design.

Which Companies Are Expanding Their Footprint In The Biguanides Market?

Major companies operating in the biguanides market are Pfizer Inc., Sanofi-Aventis LLC, Viatris Inc., Aurobindo Pharma Ltd., Cipla Ltd, Dr. Reddy’s Laboratories, Lupin Limited, Zydus Lifesciences Limited, Torrent Pharmaceuticals Limited, Intas Pharmaceuticals Ltd., Apotex Inc, Sun Pharmaceutical Industries Ltd., Glenmark Pharmaceuticals Ltd., Mylan Laboratories Ltd., Teva Pharmaceutical Industries Ltd., Alkem Laboratories Ltd., Panacea Biotech Ltd., Wanbury Ltd, USV Private Limited, Abbott Laboratories

Read the full biguanides market report here:

https://www.thebusinessresearchcompany.com/report/biguanides-global-market-report

How Is The Biguanides Market Distributed Across Key Geographic Regions?

Asia-Pacific was the largest region in the biguanides market in 2025. Middle East And Africa is expected to be the fastest-growing region in the forecast period. The regions covered in the biguanides market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Biguanides Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=15735&type=smp

Browse Through More Reports Similar to the Global Biguanides Market 2026, By The Business Research Company

Biguanides Market Report 2026

https://www.thebusinessresearchcompany.com/report/biguanides-global-market-report

Artichokes Market Report 2026

https://www.thebusinessresearchcompany.com/report/artichokes-global-market-report

Mushroom Market 2026

https://www.thebusinessresearchcompany.com/report/mushroom-market

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795